Oligonucleotide squelching reveals the mechanism of estrogen receptor autologous down-regulation

Molecular Endocrinology
S SantagatiA Maggi

Abstract

Antisense oligos complementary to the 5'-end, but not to the 3'-end, of the estrogen receptor (ER) messenger RNA caused a paradox accumulation of ER protein in MCF-7 cells. The same effect was observed after treatment of the cells with the corresponding sense oligos. The oligos interfering with ER down-regulation were demonstrated to specifically bind the ER with affinities in the nanomolar range. It is, therefore, proposed that the ER up-regulation induced by the oligos might be due to squelching of the ER (or ER-inducible proteins) from their binding site located in the 5'-end of the ER gene. We also report that transcriptionally inactive ER mutants can undergo down-regulation, and that in denaturing gels, the migration profile of ER-oligo and ER-estrogen-responsive element complexes are dissimilar. We, therefore, propose that ER can interact with DNA in different ways and at different binding sites. These observations might have important pharmacological consequences, since specific drugs could be devised to induce the ER conformation necessary to perform only selected tasks of the ER transcriptional repertoire.

Citations

Sep 15, 1999·Proceedings of the National Academy of Sciences of the United States of America·C PatroneD Lindholm
May 31, 2012·Amino Acids·Ivano EberiniElisabetta Gianazza
May 31, 2012·Climacteric : the Journal of the International Menopause Society·F-P ChenK-C Wang
Dec 17, 2009·Molecular Nutrition & Food Research·Rosa SirianniVincenzo Pezzi
Feb 27, 2004·The Journal of Biological Chemistry·Stefania CatalanoSebastiano Andó

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.